Digital Programme

This year’s digital AMR Conference will be an international forum to discuss AMR in the context of COVID-19 and beyond.

Each day will cover a focus topic with LIVE sessions and high-level panels:
Lessons learned from COVID-19 | Business Models & Policy Incentives | Global Markets | Financing & Investing | Outlook & Policy Roadmap

Registered participants will have access to on-demand versions of all sessions.

Overall theme of the day: Lessons learned from COVID-19

09:45–10:45 CEST Additional programme:
BEAM Alliance meet-up (for members only)
11:00–12:30 CEST

Additional programme:
Expert campus | Top 10 mistakes in antibacterial development 

All speakers will be announced soon.

13:30–15:00 CEST

Opening Session | Infectious diseases in the global spotlight: Why COVID-19 has an impact on AMR

Moderator: Deborah A O’Neil – CEO, NovaBiotics Ltd & Board Member, BEAM Alliance

Speakers:
Manica Balasegaram – Executive Director, GARDP
Christian Drosten – Director of Institute of Virology, Charité (tbc)
Jordi Vila – Head of Service, Biomedical Diagnostic Center, Microbiology, Hospital Clinic Barcelona (tbc)

15:15–16:15 CEST

Diagnostics | Why diagnostics are a gamechanger to control a pandemic and what this means for combatting AMR

All speakers will be announced soon.

16:30–17:30 CEST

One Health | Why it is more important than ever to think cross-sectoral

Moderator:
Ghada Zoubiane – Head of Partnerships and Stakeholder Engagement, ICARS

Speakers:
Peers Davies – Senior Lecturer in Livestock Health and Welfare Epidemiology and Population Health, University of Liverpool, CEIDR
Elmar Nimmesgern – Secretariat Lead, Global AMR R&D Hub
Timo Minssen – Founder and Managing Director, Center for Advanced Studies in Biomedical Innovation Law, University of Copenhagen
Viviana Muñoz-Tellez – Coordinator, Development, Innovation and Intellectual Property Programme (DIIP), South-Center

ALL DAY Virtual 1:1 Partnering Meetings

Overall theme of the day: Business Models & Policy Incentives

09:45 – 10:45 CEST

Expert campus | How to accelerate AMR drug development

Speakers:
Isabelle Bekeredjian-Ding – Head of Department, Paul-Ehrlich Institut
Claus Stie Kallesøe – CEO, grit42
Dirk Bumann – Professor for Infection Biology, The Center for Molecular Life Sciences, University of Basel

13:30–15:00 CEST

Business models | The AMR company of the future – Which route to success

Moderator: Erin Duffy – Chief of Research & Development, CARB-X

Speakers:
Marc Gitzinger – CEO, BioVersys AG
Cherif Bousselham – Head of EMEA (Europe, Middle East and Africa), Accelerate Diagnostics Inc.
Jean-Pierre Paccaud – Director of Business Development and Corporate Strategy, GARDP
Ken Bradley – Global Head, Infectious Disease Discovery, Roche (tbc)

15:15–16:15 CEST

SME approach | How to develop strategic decisions in a challenging and global AMR market

Moderator: Gökhan Batur – CEO, Polyphor Ltd

Speakers:
Peter Beyer – Senior Advisor Department of Essential Medicines & Health Products, WHO
Erin Duffy – Chief of Research & Development, CARB-X

16:30–17:30 CEST

AMR pull incentives | Will COVID-19 speed up or slow down implementation?

Speakers:
Colm Leonhard – Clinical Advisor/Consultant, NICE
Kevin Outterson – Professor of Law & Executive Director, CARB-X
Elmar Nimmesgern – Secretariat Lead, Global AMR R&D Hub

17:45–18:30 CEST

Diagnostics | Novel solutions to solve the reimbursement challenge

Moderator: Till Bachmann – Professor of Molecular Diagnostics and Infection, University of Edinburgh

Speakers:
Daniel Berman – Lead of the Global Health Team, Longitude Prize / Nesta
Philippe Cleuziat – Innovation Program Senior Director, bioMérieux, VALUE-Dx

ALL DAY Virtual 1:1 Partnering Meetings

Overall theme of the day: Global Markets

09:45–10:45 CEST

Expert campus | Focus on tuberculosis

All speakers will be announced soon.

11:00–12:30 CEST

Expert campus | Focus on TB diagnostics

All speakers will be announced soon.

13:30–15:00 CEST

Global markets | Why we need to think global to tackle AMR

Moderator: Marc Lemonnier – CEO, Antabio

Speakers:
Heiman Wertheim – Head of Clinical Microbiology Department, Chair, Radboud Center of Infectious Diseases (RCI)
Anand Anandkumar – CEO, Bugworks
Alexandra Cameron – Senior Technical Manager Strategy Team, UNITAID

15:15–16:15 CEST

Clinical trials | Why global networks are crucial to speed up late stage clinical development

All speakers will be announced soon.

17:45–18:30 CEST

Regulatory perspective | Current status and the post-COVID outlook for antibiotic clinical trials & approvals

Speakers:
Sumathi Nambiar – Director Division of Anti-Infective Products, Office of Infectious Diseases, FDA
Radu Botgros – Scientific Officer, Anti-infectives and Vaccines, Scientific and Regulatory Management Department, EMA (tbc)

ALL DAY Virtual 1:1 Partnering Meetings

Overall theme of the day: Financing & Investing

09:45–10:45 CEST

Start-up campus | Live pitches with jury voting hosted by Novo RepairImpact Fund

All speakers will be announced soon.

11:00–11:45 CEST

SME campus (Part I) | Focus on therapeutics

All speakers will be announced soon.

11:45–12:30 CEST

SME campus (Part II) | Focus on diagnostics

All speakers will be announced soon.

13:30–15:00 CEST

Financing resistance | Why new investors are urgently needed and where they come from

Moderator: Peter Beyer – Senior Advisor Department of Essential Medicines & Health Products, WHO

Speakers:
Thomas Cueni – Director General, IFPMA
James Anderson – Head of Corporate Government Affairs, GSK (tbc)
Silas Holland – Director Global Policy, MSD (tbc)

15:15–16:15 CEST Spotlight on UK | The Investor Year of Action on AMR
16:30–17:30 CEST

Behind the scenes | Investors’ townhall meeting

All speakers will be announced soon.

17:45–18:30 CEST

Expert campus | Perspective on late stage clinical development

All speakers will be announced soon.

ALL DAY Virtual 1:1 Partnering Meetings

Overall theme of the day: Outlook & Roadmap

09:45–10:45 CEST

Expert campus | Animal Health

All speakers will be announced soon.

11:00–12:30 CEST

Expert campus | Noval approaches in Drug development

All speakers will be announced soon.

13:30–15:00 CEST

Closing session | The future of AMR: How a new post-COVID-19 policy roadmap could look like

Moderator: Marc Gitzinger – CEO & Vice-President, BioVersys AG, BEAM Alliance

Speakers:
Tiemo Woelken – MEP S&D German, vice-chair of European Parliament MEP Interest Group on AMR
Dame Sally Davies – UK Special Envoy on Antimicrobial Resistance & former Chief Medical Officer for England (tbc)
Ramanan Laxminarayan – founder and director of the Center for Disease Dynamics, Economics & Policy (CDDEP) (tbc)

ALL DAY Virtual 1:1 Partnering Meetings

BEAM Alliance programme committee

Marc Gitzinger

CEO, BioVersys AG, CH & Vice President Board, BEAM Alliance

Marc Lemonnier

CEO, Antabio SAS

Deborah O’Neil

CEO, NovaBiotics Ltd